Loading...
AMN Healthcare Services Inc is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock has shown recent price weakness, and while there are some positive catalysts, the financial performance and lack of strong proprietary trading signals suggest waiting for a more favorable entry point.
The stock's MACD is slightly positive but contracting, RSI is neutral at 49.501, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the recent price drop of -4.35% in the regular market indicates bearish sentiment. Key support is at 16.223, with resistance at 21.074.

Analysts have raised price targets recently, indicating some optimism for the company's long-term potential. The company has a differentiated ability to handle large-scale labor disruption staffing, and early signs of industry stabilization are supportive.
The stock has experienced a significant price drop recently. Financial performance in Q4 2025 shows a net loss and declining margins, with EPS and net income down significantly year-over-year. Additionally, the stock missed EPS expectations in the latest quarter.
In Q4 2025, revenue increased by 1.84% YoY to $748.2 million. However, net income dropped by 95.90% YoY to -$7.7 million, and EPS fell by 95.92% YoY to -$0.2. Gross margin also declined by 12% YoY to 21.42%.
Analysts have mixed ratings, with some raising price targets (e.g., Citizens to $24 and Baird to $23) and maintaining Outperform or Neutral ratings. However, near-term financial impacts and uneven conditions are noted, with a more constructive long-term outlook for 2027.